The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Quality of Life with Defibrillator Therapy or Amiodarone in Heart Failure
Open accessAbstract
BACKGROUND: Implantable cardioverter-defibrillator (ICD) therapy significantly prolongs life in patients at increased risk for sudden death from depressed left ventricular function. However, whether this increased longevity is accompanied by deterioration in the quality of life is unclear. METHODS: In a randomized trial, we compared ICD therapy or amiodarone with state-of-the-art medical therapy alone in 2521 patients who had stable heart failure with depressed left ventricular function. We prospectively measured quality of life at baseline and at months 3, 12, and 30; data collection was 93 to 98% complete. The Duke Activity Status Index (which measures cardiac physical functioning) and the Medical Outcomes Study 36-Item Short-Form Mental Health Inventory 5 (which measures psychological well-being) were prespecified primary outcomes. Multiple additional quality-of-life outcomes were also examined. RESULTS: Psychological well-being in the ICD group, as compared with medical therapy alone, was significantly improved at 3 months (P=0.01) and at 12 months (P=0.003) but not at 30 months. No clinically or statistically significant differences in physical functioning among the study groups were observed. Additional quality-of-life measures were improved in the ICD group at 3 months, 12 months, or both, but there was no significant difference at 30 months. ICD shocks in the month preceding a scheduled assessment were associated with a decreased quality of life in multiple domains. The use of amiodarone had no significant effects on the primary quality-of-life outcomes. CONCLUSIONS: In a large primary-prevention population with moderately symptomatic heart failure, single-lead ICD therapy was not associated with any detectable adverse quality-of-life effects during 30 months of follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some studies have found no significant differences in overall QOL between ICD patients and other cardiac patients, 2,3 PM patients, or the general population.4”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Self-citationMoss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Hlatky, M. A., Boineau, R., Higginbotham, M. B., Lee, K. L., Mark, D. B., Califf, R. M., Cobb, F. R., & Pryor, D. B. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90496-7 · Cited by 1,747
Self-citationAmiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., DEEDWANIA, P. C., Massie, B. M., Colling, C. L., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,217
Bigger, J. T. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372201 · Cited by 1,010
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D. R., Grancelli, H., Perrone, S. V., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 913
Research works printed but not linked: 1
- Rector TS, 1987, Heart Fail, 3, 198
Cited by
Sorted by citations
Items 201–259 of 259
Benefit of CHA2 DS2 -VASc Score in Predicting Implantable Cardioverter Defibrillator Shocks
GUNAY, S., Seyis, S., & Kurmuş, Ö. (2018) · Cardiology & Vascular Research · doi:10.33425/2639-8486.1020 · Cited by 1
Device Therapy in the Heart Failure
Rhodes, T. E., & Weiss, R. (2019) · Cardiovascular medicine · doi:10.1007/978-3-319-98184-0_9 · Cited by 1
Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter-Defibrillators
Savastano, S., Baldi, E., & Brondino, N. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_21-1 · Cited by 1
Psychiatric Aspects of Sudden Cardiac Arrest and Implantable Cardioverter-Defibrillators
Savastano, S., Baldi, E., & Brondino, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_21 · Cited by 1
Sears, S. F., Kirian, K., Matchett, M., Benton, C., & Nekkanti, R. (2011) · doi:10.1002/9781118788967.ch13 · Cited by 1
Atwater, B. D., & Daubert, J. P. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01731.x · Cited by 1
Epstein, A. E. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.028 · Cited by 1
Goldenberg, L., & Huang, D. T.-C. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac652 · Cited by 1
Programmed Stimulation During Mapping and Ablation of VT
Khaykin, Y. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_39
Palliative Care in Advanced Heart Disease
Liebscher, R., & Black, F. (2012) · doi:10.1002/9781118426869.ch18
Systolische Herzinsuffizienz bei älteren Patienten
Normann, J. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-014-0853-0
Prevention of Sudden Cardiac Death in Patients with Cardiomyopathy
Chekakie, M. O. A. (2012) · InTech eBooks · doi:10.5772/27850
Preventive Effect of Amiodarone on VT/VF Events in ICD Patients with Structural Heart Diseases
Kiryu, M., Niwano, S., Kishihara, J., Aoyama, Y., Ishikawa, S., Murakami, M., Kurokawa, S., Yumoto, Y., Imaki, R., Fukaya, H., et al. (2010) · Journal of Arrhythmia · doi:10.1016/s1880-4276(10)80024-9
Electrophysiological device therapy (implantable defibrillators) in older adults
Li, W., & Olshansky, B. (2009) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0051-6
Reducing ICD Shocks for Ventricular Arrhythmias
Schoenhard, J. A., & Zei, P. C. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.013
Niwano, S., Oikawa, J., & Fukaya, H. (2013) · Journal of Arrhythmia · doi:10.1016/j.joa.2013.05.003
Webster, G., & Berul, C. I. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.947317
Implantable Cardioverter Defibrillator in Patients with Coronary Artery Disease
Goldenberg, I., & Moss, A. J. (2009) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2009.08.008
Cardiovascular implantable electronic devices : The patient perspective
Versteeg, H. (2011) · Data Archiving and Networked Services (DANS)
Device Therapy in Heart Failure
Owen, A. (2010) · Springer eBooks · doi:10.1007/978-1-84996-153-0_19
Atrial Fibrillation in Patients with Implantable
Sakhuja, R., Shah, A. J., Keebler, M., & Thakur, R. K. (2009)
IMPLANTABLE DEFIBRILLATORS EXTEND SURVIVAL WITHOUT ADVERSE EFFECTS
Joy, S. D. S. (2009) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000346941.51290.13
Kong, M. H., Al‐Khatib, S. M., Sanders, G. D., Hasselblad, V., & Peterson, E. D. (2012) · Folia Cardiologica
Implantable cardioverter defibrillators in patients with coronary artery disease
Goldenberg, I., & Moss, A. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7295-3927-2.10056-9
Knoepke, C. E. (2015) · Digital Commons - DU (University of Denver)
Impaired Mental Health‐Related Quality of Life in Patients with Idiopathic Ventricular Fibrillation
Visser, M., PEREIRA, L. C. P., Mastenbroek, M. H., Versteeg, H., & Hassink, R. J. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13034
Smith, D. I., & Duah, A. O. (2017) · InTech eBooks · doi:10.5772/66517
Dispositivos en falla cardíaca
Sénior, J. M., & Giraldo-Ramírez, N. (2016) · IATREIA
The Impact of Prolonged ICD Arrhythmia Detection
Meta-Analysis, A., Scott, P. A., & Silberbauer, J. (2014)
How to Program an ICD to Minimize Inappropriate Shocks
Wang, P. J., & Joe, W. B. (2017) · doi:10.1002/9781118820674.ch23
Bozyel, S., Aktaş, M., Mutluer, F. O., Güler, T. E., Derviş, E., Argan, O., Çelikyurt, U., Ağır, A. A., & Vural, A. (2018) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1488664
Herzinsuffizienz und Herzrhythmusstörungen
Herrmann‐Lingen, C., & Albus, C. (2011) · Elsevier eBooks · doi:10.1016/b978-3-437-21831-6.10079-6
Sham Controls in Evaluating Cardiac Procedures: A Pilot Systematic Review of RCTs
Yang, Y. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f8ke-z482
Recent Publications on Medications and Pharmacy
Sterling, J. A. (2008) · Hospital Pharmacy · doi:10.1310/hpj4311-937
O’Connor, C. M., & Stough, W. G. (2012) · doi:10.1002/9781118399378.ch5
The Year in Epidemiology, Health Services Research, and Outcomes Research
Hlatky, M. A., & Heidenreich, P. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.013
Herzinsuffizienz und –Herzrhythmusstörungen
Herrmann‐Lingen, C., & Albus, C. (2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.00079-6
Section 9: Electrophysiology Testing and the Use of Devices in Heart Failure
(2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.05.018
Mortality risk and patients' quality of life on ICD therapy: insights from SCD-HeFT
(2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1382
(2016) · Elsevier eBooks · doi:10.1016/b978-3-437-21833-0.16001-2
Rosman, L., Whited, A. L., Ford, J. H., Nekkanti, R., Cahill, J., & Sears, S. F. (2016) · Springer eBooks · doi:10.1007/978-981-287-206-7_50
QOL not diminished following ICD therapy in HF
(2008) · PharmacoEconomics & Outcomes News · doi:10.2165/00151234-200805620-00019
Implantable cardioverter–defibrillators
Cannon, J. A., & Connelly, D. T. (2022) · doi:10.1093/med/9780198766223.003.0059
Gandara, M. I., Efimov, I. R., & Aras, K. (2024) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd11100322
Selvarajah, K., Khan, P., Jahagirdar, N., Cannata, A. N., Mukherjee, R. K., Bromage, D. I., McDonagh, T. A., MURGATROYD, F. D., & Scott, P. A. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13204
Follansbee, C. W., Navarro, L. A., Feingold, B., & Arora, G. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-03833-5
van Barreveld, M., van Dessel, P. F. H. M., Buskens, E., Boersma, L. V. A., Delnoy, P. P. H. M., Tuinenburg, A. E., Theuns, D. A. M. J., van der Voort, P. H., Kimman, G. P., Verstraelen, T. E., et al. (2025) · Clinical Research in Cardiology · doi:10.1007/s00392-025-02687-4
Rakisheva, A. (2025) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaf086
Der erste ICD(implantierbarer Kardioverter-Defibrillator)-Schock
Kleemann, T., & Zahn, R. (2025) · Herz · doi:10.1007/s00059-025-05338-6
Huntelaar, M. J., Hopman, L. H. G. A., van der Lingen, A. C. J., Rijnierse, M. T., Kemme, M. J. B., Allaart, C. P., & van Halm, V. P. (2025) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70094
Recent Publications on Medications and Pharmacy
Sterling, J. A. (2008) · Hospital Pharmacy · doi:10.1310/hpj4312-1024
Huntelaar, M. J., van der Lingen, A. C. J., Rijnierse, M. T., Elshout, S., van Halm, V. P., Leeuwis, A. E., Hopman, L. H. G. A., & Allaart, C. P. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.04.004
Telec, W., Kłosiewicz, T., Dimmich, M., Szczygieł, M. B., Krzemińska, M., Wójcik, R., & Baszko, A. (2026) · Emergency Medicine International · doi:10.1155/emmi/2737258
Almarzuqi, A., Garas, M., Ju, E., Moustafa, A. T., Skanes, A., Gula, L., Leong‐Sit, P., Prestia, D., Tang, A. S., & Khan, H. R. (2026) · Research Square · doi:10.21203/rs.3.rs-10061060/v1
Mori, H., Nabeshima, T., Nagaoka, K., Fukunaga, H., Hayashi, H., Inaba, O., Isonaga, Y., Asano, S., Nitta, J., Watanabe, S., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70420
Hidekuma, T., Kanejima, Y., Ogura, A., Ota, H., & Izawa, K. P. (2026) · Journal of Clinical and Preventive Cardiology · doi:10.4103/jcpc.jcpc_14_26
Metadata
- Authors
- Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., Lee, K. L., & Bardy, G. H.
- Affiliations
- Duke Medical Center (US)
- Duke Clinical Research Institute (US)
- North Carolina State University (US)
- University of Washington (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-09-04
- Volume
- 359
- Issue
- 10
- Pages
- 999-1008
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2823628
- OpenAlex
- W2117271182
- Cited by
- 260
- References
- 19
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 8 · 2023: 1 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 6 · 2018: 13 · 2017: 18 · 2016: 16 · 2015: 20 · 2014: 16 · 2013: 19 · 2012: 22
- FWCI
- 18.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01 HL55496, U01 HL55766, U01-HL55297), U01HL055297, U01HL055766, U01HL055496)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- implantable cardioverter-defibrillator, amiodarone, heart failure, quality of life, psychological well-being, physical function, ICD shocks, sudden cardiac death, depressed left ventricular function, primary prevention
- MeSH terms
- Activities of Daily Living, Adult, Amiodarone, Anti-Arrhythmia Agents, Drug Therapy, Combination, Female, Follow-Up Studies, Heart Failure, Humans, Male, Quality of Life, Survival Analysis, Defibrillators, Implantable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review